Cite

HARVARD Citation

    Onderdonk, B. et al. (2020). Adjuvant treatment for high‐risk salivary gland malignancies and prognostic stratification based on a 20‐year single institution experience. Health science reports. 3 (4), p. n/a. [Online]. 
  
Back to record